Bartlett & Co Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.4K | Hold |
1,332
| – | – | ﹤0.01% | 679 |
|
|
2026
Q1 | $67.8K | Hold |
1,332
| – | – | ﹤0.01% | 626 |
|
|
2025
Q4 | $65.9K | Sell |
1,332
-364
| -21% | -$17K | ﹤0.01% | 616 |
|
|
2025
Q3 | $74K | Buy |
1,696
+84
| +5% | +$3.28K | ﹤0.01% | 604 |
|
|
2025
Q2 | $62.5K | Buy |
1,612
+256
| +19% | +$9.78K | ﹤0.01% | 620 |
|
|
2025
Q1 | $53.1K | Hold |
1,356
| – | – | ﹤0.01% | 639 |
|
|
2024
Q4 | $46.4K | Buy |
1,356
+37
| +3% | +$1.33K | ﹤0.01% | 665 |
|
|
2024
Q3 | $54.4K | Hold |
1,319
| – | – | ﹤0.01% | 640 |
|
|
2024
Q2 | $51.8K | Hold |
1,319
| – | – | ﹤0.01% | 650 |
|
|
2024
Q1 | $57.4K | Hold |
1,319
| – | – | ﹤0.01% | 642 |
|
|
2023
Q4 | $49.4K | Sell |
1,319
-240
| -15% | -$8.62K | ﹤0.01% | 708 |
|
|
2023
Q3 | $57K | Hold |
1,559
| – | – | ﹤0.01% | 640 |
|
|
2023
Q2 | $56K | Hold |
1,559
| – | – | ﹤0.01% | 649 |
|
|
2023
Q1 | $55.9K | Hold |
1,559
| – | – | ﹤0.01% | 554 |
|
|
2022
Q4 | $55.2K | Hold |
1,559
| – | – | ﹤0.01% | 563 |
|
|
2022
Q3 | $46.4K | Sell |
1,559
-159
| -9% | -$6.03K | ﹤0.01% | 575 |
|
|
2022
Q2 | $94.1K | Buy |
1,718
+159
| +10% | +$8.78K | ﹤0.01% | 468 |
|
|
2022
Q1 | $86.1K | Buy |
+1,559
| New | +$84.7K | ﹤0.01% | 505 |
|
|
2021
Q4 | – | Sell |
-1,559
| Closed | -$75.7K | – | 587 |
|
|
2021
Q3 | $75.7K | Sell |
1,559
-775
| -33% | -$38.9K | ﹤0.01% | 453 |
|
|
2021
Q2 | $118K | Hold |
2,334
| – | – | ﹤0.01% | 390 |
|
|
2021
Q1 | $106K | Sell |
2,334
-796
| -25% | -$36.1K | ﹤0.01% | 403 |
|
|
2020
Q4 | $146K | Sell |
3,130
-896
| -22% | -$41.2K | ﹤0.01% | 356 |
|
|
2020
Q3 | $192K | Hold |
4,026
| – | – | ﹤0.01% | 314 |
|
|
2020
Q2 | $208K | Hold |
4,026
| – | – | 0.01% | 305 |
|
|
2020
Q1 | $192K | Buy |
4,026
+896
| +29% | +$47.8K | 0.01% | 296 |
|
|
2019
Q4 | $185K | Sell |
3,130
-160
| -5% | -$8.9K | ﹤0.01% | 343 |
|
|
2019
Q3 | $177K | Buy |
3,290
+980
| +42% | +$50.4K | ﹤0.01% | 341 |
|
|
2019
Q2 | $117K | Hold |
2,310
| – | – | ﹤0.01% | 310 |
|
|
2019
Q1 | $123K | Sell |
2,310
-1,696
| -42% | -$84.7K | ﹤0.01% | 291 |
|
|
2018
Q4 | $194K | Hold |
4,006
| – | – | 0.01% | 252 |
|
|
2018
Q3 | $204K | Hold |
4,006
| – | – | 0.01% | 258 |
|
|
2018
Q2 | $204K | Sell |
4,006
-442
| -10% | -$22.3K | 0.01% | 251 |
|
|
2018
Q1 | $221K | Buy |
+4,448
| New | +$207K | 0.01% | 243 |
|
Other funds holding GSK
JEST
Bartlett & Co Wealth Management's GSK Position: Q2 2026 in Review
Bartlett & Co Wealth Management held its GSK (GSK) position steady in Q2 2026 at 1,332 shares worth $70.4K. The position accounts for ﹤0.01% of the portfolio, ranked #679.
Bartlett & Co Wealth Management first reported a position in GSK in Q1 2018 and has held it in 33 quarters since. The position peaked at $221K in Q1 2018. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Bartlett & Co Wealth Management held 1,332 shares of GSK worth $70.4K as of Q2 2026.
- Bartlett & Co Wealth Management left its GSK share count unchanged in Q2 2026.
- GSK made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #679 holding.
- Bartlett & Co Wealth Management first reported a position in GSK in Q1 2018 and has held it in 33 quarters since.
- Bartlett & Co Wealth Management's GSK position peaked at $221K in Q1 2018.
- 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.